lysine-3,4-methylenedioxyamphetamine
赖氨酸-3,4-亚甲二氧基苯丙胺
Report date: 2025/08/14 10:17:30
NME
Base Information
Drug Namelysine-3,4-methylenedioxyamphetamine
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Hospital Basel
China Registration ClassN/A
Develop Information
Active CompaniesUniversity Hospital Basel
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A